Timedora

2 Acid–Base Disorders and Compensation

Learn to interpret arterial blood gases, distinguish primary acid–base disorders from compensation and mixed processes, and apply nursing priorities to assessment and care.

ABG essentials and core patterns

An helps assess acid–base status and oxygenation. Common adult reference ranges are pH 7.357.35–7.457.45, PaCO₂ 3535–4545 mm Hg, and HCO₃⁻ 2222–2626 mEq/L, although ranges can vary by laboratory. Interpret results alongside the patient’s condition, electrolytes, and laboratory reference ranges, not in isolation.

PaCO₂ represents the respiratory component, while bicarbonate represents the metabolic component. ABG bicarbonate is generally calculated from pH and PaCO₂. means blood pH is below 7.357.35; means it is above 7.457.45. Acidosis and alkalosis describe processes that tend to lower or raise pH, respectively, so a patient may have an acid–base disorder even when pH is within its reference range.

In a primary respiratory disorder, pH and PaCO₂ move in opposite directions. In a primary metabolic disorder, pH and HCO₃⁻ move in the same direction.

A systematic interpretation method

Use a consistent sequence to interpret results:

  1. Assess pH and classify it as , , or within the reference range.

  2. Identify which primary change fits the pH: PaCO₂ for a respiratory process or HCO₃⁻ for a metabolic process.

  3. Check whether is appropriate for the disorder and its duration. moves pH toward normal, but does not by itself explain a value outside the expected range.

  4. If metabolic acidosis is present, calculate the :

AG=Na+−(Cl−+HCO3−)\mathrm{AG} = \mathrm{Na^+} - (\mathrm{Cl^-} + \mathrm{HCO_3^-})

A high gap may indicate unmeasured acids; consider albumin when interpreting the gap.
5. Compare the results with the clinical picture. Unexpected or markedly abnormal PaCO₂ and HCO₃⁻ that do not fit one simple process suggest a .

The four primary disorders

Respiratory disorders

Respiratory acidosis has low pH and high PaCO₂; HCO₃⁻ rises with . Causes include hypoventilation from airway or lung disease, central nervous system (CNS)-depressing drugs, impaired respiratory muscles, or chest-wall restriction. Manifestations may reflect the cause and include dyspnea, wheezing, headache, confusion, or reduced alertness. Severe hypercapnia can cause neurologic deterioration.

Respiratory alkalosis has high pH and low PaCO₂; HCO₃⁻ falls with . It can result from hyperventilation associated with hypoxemia, pulmonary disease including pulmonary embolism, fever, pain, sepsis, pregnancy, or anxiety. Acute hypocapnia may cause light-headedness, confusion, tingling around the mouth or in the limbs, cramps, or carpopedal spasm. Do not automatically attribute respiratory alkalosis to anxiety; assess for serious causes such as hypoxemia, sepsis, and pulmonary embolism.

Metabolic disorders

Metabolic acidosis has low pH and low HCO₃⁻; PaCO₂ falls with respiratory . Causes include acid accumulation, such as ketoacidosis or lactic acidosis, reduced renal acid excretion, toxins, or bicarbonate loss from the gastrointestinal (GI) tract or kidneys. Findings depend on the cause. Severe may cause nausea, vomiting, malaise, deep breathing, hypotension, arrhythmias, or altered mental status.

Metabolic alkalosis has high pH and high HCO₃⁻; PaCO₂ rises with respiratory . Causes include vomiting or gastric suction, diuretics, volume or chloride depletion, hypokalemia, or excess alkali. Severe may cause headache, lethargy, weakness, tingling, muscle cramps, tetany, seizures, or arrhythmias.

Causes and clinical effects vary with severity, speed of onset, and underlying illness.

Expected

Expected is estimated using reference values PaCO₂ 4040 mm Hg and HCO₃⁻ 2424 mEq/L. These bedside rules of thumb estimate the expected response; small differences may reflect rounding or clinical context. An observed value outside the expected range raises concern for another primary disorder.

  • Metabolic acidosis: predicts expected PaCO₂:

    Expected PaCO₂=(1.5×HCO3−)+8±2 mm Hg\text{Expected PaCO₂} = (1.5 \times \mathrm{HCO_3^-}) + 8 \pm 2\ \text{mm Hg}
  • Metabolic alkalosis: PaCO₂ rises about 0.60.6–0.750.75 mm Hg for each 11 mEq/L rise in HCO₃⁻ above 2424 mEq/L. usually does not raise PaCO₂ above about 5555 mm Hg.

  • Acute respiratory acidosis: HCO₃⁻ rises about 11–22 mEq/L for each 1010 mm Hg rise in PaCO₂ above 4040 mm Hg.

  • Chronic respiratory acidosis: HCO₃⁻ rises about 33–44 mEq/L for each 1010 mm Hg rise in PaCO₂ above 4040 mm Hg. Renal develops over days.

  • Acute respiratory alkalosis: HCO₃⁻ falls about 11–22 mEq/L for each 1010 mm Hg fall in PaCO₂ below 4040 mm Hg.

  • Chronic respiratory alkalosis: HCO₃⁻ falls about 44–55 mEq/L for each 1010 mm Hg fall in PaCO₂ below 4040 mm Hg. Renal develops over days.

For example, when HCO₃⁻ is 1212 mEq/L, gives expected PaCO₂ of (1.5×12)+8=26±2(1.5 \times 12) + 8 = 26 \pm 2 mm Hg. A measured PaCO₂ of 2525 mm Hg is within the expected range. A substantially higher value suggests additional respiratory acidosis; a substantially lower value suggests additional respiratory alkalosis.

Metabolic disorders are compensated mainly by changes in ventilation. Respiratory disorders are compensated mainly by the kidneys, and chronic respiratory takes days.

Recognizing mixed disorders

A means that two or more primary acid–base processes are present. Do not label a change as if it exceeds the expected response. For example, metabolic acidosis should lower PaCO₂ only to the range predicted by ; a PaCO₂ well below that range indicates an additional respiratory alkalosis.

Two processes can move pH in opposite directions and produce a near-normal pH, masking the severity of the underlying abnormalities. Useful clues include:

  • PaCO₂ higher than Winter’s predicted range in metabolic acidosis suggests metabolic acidosis plus respiratory acidosis.

  • PaCO₂ lower than Winter’s predicted range in metabolic acidosis suggests metabolic acidosis plus respiratory alkalosis.

  • An HCO₃⁻ change greater than expected for an acute respiratory disorder suggests considering a second metabolic process or a chronic respiratory disorder.

  • Near-normal pH with abnormal PaCO₂ and HCO₃⁻ calls for checking the direction of change and expected ; opposing primary disorders may be present.

  • In high-anion-gap metabolic acidosis, comparing the rise in with the fall in HCO₃⁻ can reveal an additional metabolic process.

Nursing assessment and interventions

Nursing care supports rapid recognition, patient safety, and treatment of the underlying cause. Follow local protocols and prescribed orders; interventions depend on the patient’s condition.

  • Assess first: Evaluate airway, respiratory effort and rate, oxygenation, circulation, mental status, vital signs, and relevant history, including vomiting, diarrhea, medications, diabetes, lung disease, or possible toxin exposure. Escalate promptly for respiratory distress, worsening consciousness, hemodynamic instability, or a critically abnormal ABG.

  • Trend and communicate: Review ABGs alongside electrolytes, renal function, glucose, lactate, and other relevant results. Note oxygen delivery and ventilator settings when applicable. Report changes and communicate the suspected disorder and clinical findings to the care team.

  • Support breathing and oxygenation as indicated: Position the patient, maintain prescribed oxygen or ventilatory support, monitor response, and collaborate with respiratory therapy. Do not independently change ventilator settings or rapidly alter a chronic CO₂ level.

  • Address the cause under the care plan: Examples include supporting evaluation of hypoventilation or infection, monitoring for GI fluid losses, and administering prescribed fluids or electrolyte replacement. Treatment is cause-specific; bicarbonate and other corrective therapies require clinical assessment and orders.

  • Use safety precautions: Monitor for arrhythmias, weakness, seizures, or neuromuscular irritability when indicated. Do not use paper-bag rebreathing for suspected hyperventilation; it can worsen hypoxia or interfere with for an unrecognized metabolic acidosis.

Worked interpretation examples

Metabolic acidosis with expected

For pH 7.297.29, PaCO₂ 2525 mm Hg, and HCO₃⁻ 1212 mEq/L, the primary disorder is metabolic acidosis: pH and HCO₃⁻ are low. predicts PaCO₂ of (1.5×12)+8±2=26±2(1.5 \times 12) + 8 \pm 2 = 26 \pm 2 mm Hg. The measured PaCO₂ of 2525 mm Hg is within range, indicating appropriate respiratory .

Acute respiratory acidosis

After hypoventilation following a CNS-depressing medication, an ABG shows pH 7.277.27, PaCO₂ 6060 mm Hg, and HCO₃⁻ 2626 mEq/L. The high PaCO₂ explains the . PaCO₂ is 2020 mm Hg above 4040; an acute rise predicts an HCO₃⁻ increase of about 22 mEq/L from 2424 to approximately 2626 mEq/L, consistent with expected early . Assess ventilation and escalate care according to patient status and protocol.

Metabolic acidosis plus respiratory alkalosis

For pH 7.467.46, PaCO₂ 2020 mm Hg, and HCO₃⁻ 1414 mEq/L, low HCO₃⁻ indicates metabolic acidosis. predicts PaCO₂ of (1.5×14)+8±2=29±2(1.5 \times 14) + 8 \pm 2 = 29 \pm 2 mm Hg. The measured PaCO₂ of 2020 mm Hg is lower than expected, indicating a second primary process, respiratory alkalosis. The low PaCO₂ explains why pH is alkalemic despite low bicarbonate.

Metabolic alkalosis with expected

For pH 7.497.49, PaCO₂ 4949 mm Hg, and HCO₃⁻ 3636 mEq/L, elevated pH and HCO₃⁻ indicate metabolic alkalosis. HCO₃⁻ is 1212 mEq/L above 2424; expected PaCO₂ rises roughly 0.60.6–0.75×120.75 \times 12, giving about 4747–4949 mm Hg. The measured PaCO₂ of 4949 mm Hg is consistent with that estimate.

Near-normal pH with a

For pH 7.407.40, PaCO₂ 2020 mm Hg, and HCO₃⁻ 1212 mEq/L, low HCO₃⁻ is consistent with metabolic acidosis. predicts PaCO₂ of 26±226 \pm 2 mm Hg, but the measured value of 2020 mm Hg is lower than expected, showing an additional respiratory alkalosis. The opposing processes bring pH into the reference range; a normal pH does not rule out a serious .